HHS to Judge: Don’t Revisit the 340B Lawsuit We Lost


David Ivill said he expects that new regulations to clarify various parts of the federal government’s 340B discount drug program will not be released before the end of the year, a delay due in part to legal battles over the government’s decision earlier this year to compel orphan drug discounts from pharmaceutical companies. Read the full article